Gottlieb FDA nomination praised Pharmaceutical manufacturers and some consumer groups praised President Donald Trump’s nomination of Dr. Scott Gottlieb as the new FDA commissioner. HIV dual therapy shows promise February 27, 2017 A dual-drug regiment to treat HIV could soon be a reality, according to results presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Tests help aid in antibiotic control February 27, 2017 FDA recently approved 2 tests that will aid healthcare providers in determining which antibiotics are needed, leading to better antibiotics management. Popular asthma inhaler now expanded to kids February 21, 2017 By Christine Blank A leading asthma inhaler will now be available to additional younger asthma patients, after FDA approved Spiriva Respimat (Boehringer Ingelheim) for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. Psoriasis drug approved with boxed warning February 21, 2017 By Christine Blank A new drug to treat moderate-to-severe plaque psoriasis carries a black box warning that suicidal ideas and behavior, including completed suicides, have occurred in patients during the drug’s clinical trials. Muscular dystrophy drug launch halts after pricing concerns February 14, 2017 By Christine Blank Marathon Pharmaceuticals is temporarily pausing the launch of its drug to treat a rare form of muscular dystrophy (MD) after concerns over its $89,000 price tag. Diabetic patients challenge insulin makers February 06, 2017 By Christine Blank In the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers. Will Trump’s FDA picks speed drug approvals? January 31, 2017 By Christine Blank Three candidates that President Donald Trump is considering for FDA Commissioner are likely to speed drug approvals, analysts say. Drug distributor pays record fine January 24, 2017 By Christine Blank McKesson Corp., one of the largest distributors of pharmaceuticals, agreed to pay a record civil penalty for alleged violations of the Controlled Substances Act. Constipation drug wins approval January 23, 2017 By Christine Blank FDA approved plecanatide (Trulance, Synergy Pharmaceuticals) for adults with chronic idiopathic constipation.